BEAMNasdaq United States
Market cap
$2.838 B
$27.48 +0.84%
Close of 7 Aug 2026
Revenue
$139.7M
#2418 by revenue
Earnings
-$80.0M
Loss-making
Shares outstanding
103,287,665
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Beam Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.